SF1

Across TCGA pan-cancer cohorts, SF1 mass-spec protein differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of SF1’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where SF1 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types SF1 is over-expressed in tumor.

LSCC, LUAD, and COAD are the cancer types where SF1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SF1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LSCC	Male	II,III,IV	+0.292	<.001	9	view →
LUAD	Female	All	+0.239	<.001	9	view →
COAD	Male	III,IV	+0.214	<.001	9	view →
HNSC	Male	III,IV	+0.166	<.001	8	view →
CCRCC	Male	All	+0.094	<.001	6	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

SF1–LSCC

Open the LSCC breakdown →